Cargando…

Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial

INTRODUCTION: Treatment options for adults with attention deficit hyperactivity disorder (ADHD) are limited. The study was conducted to confirm the clinically effective and safe dose of methylphenidate hydrochloride modified-release (MPH-LA) in adults with ADHD and evaluate the maintenance of effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huss, Michael, Ginsberg, Ylva, Tvedten, Torbjorn, Arngrim, Torben, Philipsen, Alexandra, Carter, Katherine, Chen, Chien-Wei, Kumar, Vinod
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905180/ https://www.ncbi.nlm.nih.gov/pubmed/24371021 http://dx.doi.org/10.1007/s12325-013-0085-5

Ejemplares similares

Open-Label Dose Optimization of Methylphenidate Modified Release Long Acting (MPH-LA): A Post Hoc Analysis of Real-Life Titration from a 40-Week Randomized Trial
por: Huss, Michael, et al.
Publicado: (2014)

Long-Term (1 Year) Safety and Efficacy of Methylphenidate Modified-Release Long-Acting Formulation (MPH-LA) in Adults with Attention-Deficit Hyperactivity Disorder: A 26-Week, Flexible-Dose, Open-Label Extension to a 40-Week, Double-Blind, Randomised, Placebo-Controlled Core Study
por: Ginsberg, Y., et al.
Publicado: (2014)

Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Nair, Rajasree, et al.
Publicado: (2009)

Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)

Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder
por: Teuscher, Nathan S, et al.
Publicado: (2015)

The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
por: İsmi, Onur, et al.
Publicado: (2018)

The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate
por: Shem-Tov, Sharon, et al.
Publicado: (2019)

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
por: Pitzianti, Maria Bernarda, et al.
Publicado: (2020)

Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
por: Shirafkan, Hoda, et al.
Publicado: (2020)

Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
por: Mandali, Alekhya, et al.
Publicado: (2021)

Pica in an Adolescent with Attention Deficit Hyperactivity Disorder responsive to Methylphenidate
por: Bourgou, Soumaya, et al.
Publicado: (2021)

Continuity in Methylphenidate Treatment of Adults With Attention-Deficit/Hyperactivity Disorder
por: Olfson, Mark, et al.
Publicado: (2007)

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder
por: Newcorn, Jeffrey H., et al.
Publicado: (2017)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder
por: Liu, Feng, et al.
Publicado: (2006)

Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial
por: Kooij, J J Sandra, et al.
Publicado: (2013)

The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder
por: Sopko, Michael A., et al.
Publicado: (2010)

Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS)
por: Findling, Robert L., et al.
Publicado: (2014)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
por: Pagerols, Mireia, et al.
Publicado: (2018)

Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
por: Jaeschke, Rafał R., et al.
Publicado: (2021)

Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
por: Pereira Ribeiro, Johanne, et al.
Publicado: (2021)

Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
por: Arnett, Anne B., et al.
Publicado: (2022)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss, Michael, et al.
Publicado: (2016)

Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study
por: Wigal, Sharon B., et al.
Publicado: (2015)

Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate
por: Buitelaar, J. K., et al.
Publicado: (2012)

A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR(®)) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder
por: Adjei, Akwete L., et al.
Publicado: (2020)

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
por: Hodgkins, Paul, et al.
Publicado: (2012)

Methylphenidate Transdermal System in Attention-Deficit Hyperactivity Disorder in Adolescentsy: Profile Report
por: Keating, Gillian M.
Publicado: (2012)

Risperidone Versus Methylphenidate in Treatment of Preschool Children With Attention-Deficit Hyperactivity Disorder
por: Arabgol, Fariba, et al.
Publicado: (2015)

Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia
por: Golubchik, Pavel, et al.
Publicado: (2014)

The effect of methylphenidate-OROS(®) on the narrative ability of children with attention-deficit hyperactivity disorder
por: Rausch, Tessa L., et al.
Publicado: (2017)

The effect of adding ferrous sulfate to methylphenidate on attention-deficit/hyperactivity disorder in children
por: Panahandeh, Gholamreza, et al.
Publicado: (2017)

Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
por: Gomez-Sanchez, Clara I., et al.
Publicado: (2017)

Methylphenidate and the risk of burn injury among children with attention-deficit/hyperactivity disorder
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2020)

Association Between Tic Aggravation and Methylphenidate in Youth With Attention-Deficit/Hyperactivity Disorder
por: Cha, Jung Yoon, et al.
Publicado: (2021)

Effects of Iron Supplementation on Attention Deficit Hyperactivity Disorder in Children Treated with Methylphenidate
por: Tohidi, Sepehr, et al.
Publicado: (2021)

Psychosis Induced by Methylphenidate in Children and Young Patients With Attention-Deficit Hyperactivity Disorder
por: Pasha, Khadija, et al.
Publicado: (2023)

The effect of methylphenidate on pain perception thresholds in children with attention deficit hyperactivity disorder
por: Bozkurt, Abdullah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qcto6c97ka2q4nr1mjtesjk5be